+34 679 490 537info@nanbiosis.com

Welcome to Nanbiosis – ICTS

NANBIOSIS is one of the 29 ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Council for Science Policy, Technology and Innovation (MINECO).  NANBIOSIS provides complete services for the production and characterization of nanomaterials, biomaterials and systems in biomedicine. This ICTS is integrated by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Jesus Uson Minimally Invasive Surgery Centre (JUMISC).

Platform units

NANBIOSIS is organized in five platforms distributed in Spain: Alava, Badajoz, Barcelona, Cáceres, Madrid, Valencia and Zaragoza. This infrastructure provides high technological resources and high qualified personal, and offers open services to the scientific community.

News

11 Jan

Improving biomaterials imaging for nanotechnology: rapid methods for protein localization at ultrastructural level

New publication of Tony Villaverde, Scientific Director of Unit 1 of NANBIOSIS acepted by Biotechnology Journal: The preparation of biological samples for electron microscopy is material- and time-consuming because it is often based on long protocols that also may produce artifacts. Protein labeling for transmission electron microscopy (TEM) is such an example, taking several days. However, [...]

29 Dec

Polyurethane and polyurea nanoparticle (PUUa), improves cancer therapy

The national consortium led by the research group of Addressing and Drug Release CIBBIM – Nanomedicine of the Vall d’Hebron Research Institute (VHIR) and led by Dr. Ibane Abasolo, Scientific Coordinataror of Unit 20 of NANBIOSIS, has shown improvement in the effectiveness and specificity of targeted therapy against cancer through the use of polyurethane-polyurea nanocapsules [...]

27 Dec

Conxita Solans receives the lectureship award of the Japan Research Institute of Materials Technology

Prof. Conxita Solans (Nanostructured liquid characterization unit 12 of NANBIOSIS) received the lectureship award of the Japan Research Institute of Materials Technology from Prof. Masahiko Abe, Director of the Institute. Prof. Solans delivered her lecture during the meeting held in Noda (Japan) on December 1st, 2017.[...]

Next Events

SEE ALL EVENTS

About Nanbiosis

1. PLATFORM Biomolecules Production 2. PLATFORM Biomaterials and Nanomaterials Production 3. PLATFORM Tissue, Biomaterial and Surface Characterization 4. PLATFORM Bioimaging 5. PLATFORM High Performance Computing

Nanbiosis: Catalog 2015

The Spanish Strategy for Science, Technology and Innovation 2013-2020, adopted by the Council of Ministers on February 1st, 2013, includes the update of the “National Scientific and Technological Infrastructure Map (ICTS)” for the period 2013-2016 and 2016-2020.

 

The so-called singular scientific and technical infrastructures (ICTS) are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas ranging from the life sciences to astrophysics or engineering, distributed throughout the Spanish territory.

NANBIOSIS has been recognized by the Spanish Government as one of these 29 UNIQUE existing ICTS, which are OPEN to competitive access to users of the whole research community in the public and private sector.

FAQ

What is NANBIOSIS?

It is one of the 29 UNIQUE ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Government (MINECO) which is managed by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Center for Minimally Invasive Surgery Jesus Uson (JUMISC).
NANBIOSIS coordinates 27 complementary services under a single contact point model.

Which kind of services offers the platform units?

NANBIOSIS provides a complete service that includes the design and production of biomaterials and nanomaterials and their nanoconjugates, and the characterization of these bio-/nanomaterials, tissues and medicals devices from a physic-chemical, functional, toxicological and biological (including preclinical validation) point of view, focused also on biomedical applications such as: IVDs, biosensors, regenerative medicine, drug delivery, therapeutic agents or MRI contrast agents and medical devices. A Unit dedicated to high performance computing is also included for those technological applications with large scale computational demand.

Who can use these services?

NANABIOSIS is OPEN to users of the whole research community in the public and private sector.
Order request Access protocolSurvey

Our figures

0

Units

0

Scientists linked to ICTS

0

Projects since 2008

0

Services since 2008

0

Publications since 2008

0

M€ investment

Nanbiosis